(JEF) Jefferies Financial - Overview
Stock: Investment Banking, Capital Markets, Asset Management, Prime Brokerage, Advisory
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.77% |
| Yield on Cost 5y | 9.18% |
| Yield CAGR 5y | 61.53% |
| Payout Consistency | 23.7% |
| Payout Ratio | 56.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 38.5% |
| Relative Tail Risk | -0.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.36 |
| Alpha | -44.28 |
| Character TTM | |
|---|---|
| Beta | 1.784 |
| Beta Downside | 1.867 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.49% |
| CAGR/Max DD | 0.37 |
Description: JEF Jefferies Financial January 03, 2026
Jefferies Financial Group Inc. (NYSE:JEF) is a diversified financial services firm that operates globally across investment banking, capital markets, and asset management. Its two-segment model delivers advisory and underwriting services for M&A, debt financing, restructurings, and loan syndications, while also providing prime brokerage, equities research, wealth management, and foreign-exchange trading.
Beyond traditional banking, Jefferies manages a suite of alternative-asset platforms covering distressed debt, government and municipal securities, leveraged loans, emerging-market debt, and credit-derivative products. The firm serves a broad client base that includes public and private corporations, sponsors, institutional investors, and government entities. The company rebranded from Leucadia National Corporation in 2018 and is headquartered in New York.
Key metrics from the most recent fiscal year (2023) show revenue of roughly $2.5 billion, net income of $210 million, and assets under management (AUM) of about $30 billion, reflecting a modest but stable profit margin of 8.4 %. The business is sensitive to the prevailing interest-rate environment: higher rates tend to boost demand for debt underwriting and credit-linked products, while also influencing M&A activity and loan-syndication volumes.
For deeper quantitative insights, you might explore ValueRay’s detailed valuation models for JEF.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 710.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -0.43 > 1.0 |
| NWC/Revenue: 113.4% < 20% (prev 265.2%; Δ -151.8% < -1%) |
| CFO/TA -0.01 > 3% & CFO -659.2m > Net Income 710.5m |
| Net Debt (-14.04b) to EBITDA (1.06b): -13.21 < 3 |
| Current Ratio: 7.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (222.7m) vs 12m ago -0.42% < -2% |
| Gross Margin: 59.67% > 18% (prev 0.59%; Δ 5908 % > 0.5%) |
| Asset Turnover: 15.42% > 50% (prev 16.34%; Δ -0.92% > 0%) |
| Interest Coverage Ratio: 0.25 > 6 (EBITDA TTM 1.06b / Interest Expense TTM 3.48b) |
Altman Z'' 1.65
| A: 0.16 (Total Current Assets 14.04b - Total Current Liabilities 1.77b) / Total Assets 76.01b |
| B: 0.11 (Retained Earnings 8.57b / Total Assets 76.01b) |
| C: 0.01 (EBIT TTM 871.0m / Avg Total Assets 70.19b) |
| D: 0.13 (Book Value of Equity 8.40b / Total Liabilities 65.37b) |
| Altman-Z'' Score: 1.65 = BB |
Beneish M -2.17
| DSRI: 1.15 (Receivables 8.56b/7.21b, Revenue 10.82b/10.52b) |
| GMI: 0.99 (GM 59.67% / 59.12%) |
| AQI: 2.18 (AQ_t 0.80 / AQ_t-1 0.37) |
| SGI: 1.03 (Revenue 10.82b / 10.52b) |
| TATA: 0.02 (NI 710.5m - CFO -659.2m) / TA 76.01b) |
| Beneish M-Score: -2.17 (Cap -4..+1) = BB |
What is the price of JEF shares?
Over the past week, the price has changed by -3.66%, over one month by -11.05%, over three months by +11.32% and over the past year by -20.82%.
Is JEF a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JEF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 74.7 | 26.7% |
| Analysts Target Price | 74.7 | 26.7% |
| ValueRay Target Price | 68.9 | 16.8% |
JEF Fundamental Data Overview February 02, 2026
P/E Forward = 14.7929
P/S = 1.7186
P/B = 1.1939
P/EG = 1.7832
Revenue TTM = 10.82b USD
EBIT TTM = 871.0m USD
EBITDA TTM = 1.06b USD
Long Term Debt = 21.40b USD (from longTermDebt, last quarter)
Short Term Debt = 1.77b USD (from shortTermDebt, last quarter)
Debt = 1.77b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -14.04b USD (from netDebt column, last quarter)
Enterprise Value = 344.4m USD (12.62b + Debt 1.77b - CCE 14.04b)
Interest Coverage Ratio = 0.25 (Ebit TTM 871.0m / Interest Expense TTM 3.48b)
EV/FCF = -0.40x (Enterprise Value 344.4m / FCF TTM -866.6m)
FCF Yield = -251.6% (FCF TTM -866.6m / Enterprise Value 344.4m)
FCF Margin = -8.01% (FCF TTM -866.6m / Revenue TTM 10.82b)
Net Margin = 6.56% (Net Income TTM 710.5m / Revenue TTM 10.82b)
Gross Margin = 59.67% ((Revenue TTM 10.82b - Cost of Revenue TTM 4.37b) / Revenue TTM)
Gross Margin QoQ = 59.61% (prev 60.30%)
Tobins Q-Ratio = 0.00 (Enterprise Value 344.4m / Total Assets 76.01b)
Interest Expense / Debt = 49.79% (Interest Expense 880.0m / Debt 1.77b)
Taxrate = 14.82% (37.5m / 253.2m)
NOPAT = 741.9m (EBIT 871.0m * (1 - 14.82%))
Current Ratio = 7.95 (Total Current Assets 14.04b / Total Current Liabilities 1.77b)
Debt / Equity = 0.17 (Debt 1.77b / totalStockholderEquity, last quarter 10.64b)
Debt / EBITDA = -13.21 (Net Debt -14.04b / EBITDA 1.06b)
Debt / FCF = 16.21 (negative FCF - burning cash) (Net Debt -14.04b / FCF TTM -866.6m)
Total Stockholder Equity = 10.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.01% (Net Income 710.5m / Total Assets 76.01b)
RoE = 6.83% (Net Income TTM 710.5m / Total Stockholder Equity 10.40b)
RoCE = 2.74% (EBIT 871.0m / Capital Employed (Equity 10.40b + L.T.Debt 21.40b))
RoIC = 2.23% (NOPAT 741.9m / Invested Capital 33.27b)
WACC = 16.17% (E(12.62b)/V(14.39b) * Re(12.49%) + D(1.77b)/V(14.39b) * Rd(49.79%) * (1-Tc(0.15)))
Discount Rate = 12.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.42%
Fair Price DCF = unknown (Cash Flow -866.6m)
EPS Correlation: 17.38 | EPS CAGR: -9.38% | SUE: -0.47 | # QB: 0
Revenue Correlation: 89.41 | Revenue CAGR: 12.23% | SUE: 3.24 | # QB: 2
EPS next Quarter (2026-05-31): EPS=0.99 | Chg30d=+0.043 | Revisions Net=+1 | Analysts=5
EPS current Year (2026-11-30): EPS=4.26 | Chg30d=+0.160 | Revisions Net=-2 | Growth EPS=+50.5% | Growth Revenue=+14.3%
EPS next Year (2027-11-30): EPS=5.60 | Chg30d=+0.245 | Revisions Net=-1 | Growth EPS=+31.4% | Growth Revenue=+8.7%